IRIS
GRASSADONIA, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.673
EU - Europa 4.360
AS - Asia 3.676
SA - Sud America 477
AF - Africa 68
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.552
SG - Singapore 1.635
RU - Federazione Russa 1.062
CN - Cina 910
IT - Italia 740
IE - Irlanda 544
VN - Vietnam 403
BR - Brasile 385
SE - Svezia 379
FR - Francia 345
UA - Ucraina 345
GB - Regno Unito 325
DE - Germania 268
TR - Turchia 238
IN - India 133
HK - Hong Kong 98
FI - Finlandia 91
CA - Canada 62
BD - Bangladesh 53
PL - Polonia 50
JP - Giappone 43
MX - Messico 38
BE - Belgio 35
NL - Olanda 35
CZ - Repubblica Ceca 29
IQ - Iraq 29
ZA - Sudafrica 28
ES - Italia 27
AR - Argentina 26
AT - Austria 21
AU - Australia 20
KR - Corea 18
LT - Lituania 16
CO - Colombia 13
EG - Egitto 13
PK - Pakistan 12
SA - Arabia Saudita 12
VE - Venezuela 12
RO - Romania 10
UZ - Uzbekistan 10
EC - Ecuador 9
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CL - Cile 8
JO - Giordania 8
PT - Portogallo 8
TW - Taiwan 8
JM - Giamaica 7
PE - Perù 7
MA - Marocco 6
MY - Malesia 6
NZ - Nuova Zelanda 6
PY - Paraguay 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
IL - Israele 5
OM - Oman 5
AL - Albania 4
KZ - Kazakistan 4
PH - Filippine 4
TN - Tunisia 4
AZ - Azerbaigian 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
KW - Kuwait 3
LB - Libano 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
LU - Lussemburgo 2
MT - Malta 2
PS - Palestinian Territory 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
Totale 14.283
Salva come PNG Salva come JPEG
Città #
Singapore 1.257
San Jose 782
Chandler 657
Dublin 532
Jacksonville 436
Ashburn 432
Dallas 268
Beijing 256
Princeton 203
Los Angeles 175
Southend 166
The Dalles 145
Santa Clara 136
Izmir 134
Nanjing 128
Council Bluffs 125
Ho Chi Minh City 124
New York 101
Chieti 95
Pescara 95
Hong Kong 90
Ann Arbor 84
Dearborn 84
Wilmington 84
Altamura 83
Hanoi 77
Munich 76
Boardman 67
Cambridge 62
Tongling 60
Buffalo 49
Moscow 49
Dong Ket 40
Redondo Beach 39
São Paulo 39
Nanchang 37
Tokyo 37
Rome 36
Brussels 32
Nuremberg 32
Orem 32
Denver 30
Brooklyn 29
London 29
Frankfurt am Main 28
Milan 28
Washington 28
Woodbridge 28
Hefei 27
Montreal 27
Amsterdam 26
Atlanta 25
Chicago 24
Da Nang 24
Warsaw 24
Brno 23
Hebei 22
Houston 21
Kunming 21
Shenyang 21
Norwalk 20
Stockholm 20
Tianjin 20
Boston 19
Johannesburg 19
Chennai 18
Jiaxing 18
Kraków 18
St Louis 16
Helsinki 15
Mexico City 15
Poplar 15
Seoul 15
Falls Church 14
Phoenix 14
Turku 14
Changsha 13
Lappeenranta 13
Manchester 13
Rio de Janeiro 13
City of London 12
Ancona 11
Grevenbroich 11
Hyderabad 11
Melbourne 11
Vienna 11
Cairo 10
Haiphong 10
Hangzhou 10
Memphis 10
Seattle 10
Toronto 10
Baghdad 9
Guangzhou 9
Ninh Bình 9
Padua 9
Tashkent 9
Amman 8
Augusta 8
Belo Horizonte 8
Totale 8.439
Salva come PNG Salva come JPEG
Nome #
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 848
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 192
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 184
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 180
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 178
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 174
The Role of the Environment and Type of Exercise on Acute Adrenal Modulation and Perceived Distress of Breast Cancer Survivors Practising Light-Intensity Physical Exercise 174
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 167
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 167
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 165
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 161
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 161
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 159
Gli analoghi sintetici delle glicoamine come potenziali nuovi farmaci nella prevenzione delle metastasi 158
Exosomes as pleiotropic players in pancreatic cancer 158
Occupational allergy: is there a role for nanoparticles? 154
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 153
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 151
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 150
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 149
A novel serum test using interferon for early detection of tumor reccurrence in cancer patients after radical surgery. 148
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 148
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 148
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 146
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 145
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 144
New Targets for Therapy in Pancreatic Cancer 144
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 144
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 142
Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice. 142
Glicomimetici quali potenziali nuovi farmaci per la prevenzione delle metastasi. 140
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 137
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. 134
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 134
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 133
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 132
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 131
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 131
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 130
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 126
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 126
TGF-β-1 increases 90K tumor associated antigen gene expression by increasing upstream regulatory factor binding to the minimal promoter. 125
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 125
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 125
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 124
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 124
Principali effetti collaterali delle terapie mediche 122
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 121
Tumor-derived microvesicles: The metastasomes. 121
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 121
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. 120
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study 120
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 120
Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey 118
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 118
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 117
Alectinib induced regression of renal and hepatic cysts caused by crizotinib 117
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 114
Prognostic value of gender and primary tumor location in metastatic colon cancer 114
Circadian timing of chemotherapeutic agents:a phase II study of 5-fluoro-2-deoxyuridine in gastrointestinal cancer and renal cell carcinoma 112
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 112
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies? 112
La stimolazione dinamica con IFN-α per la diagnosi precoce di ripresa di malattia in pazienti NED 110
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial 109
Regolazione, funzione ed espressione genica dell’antigene tumore-associato 90K/AC-2 BP 108
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer 108
Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: A systematic review 108
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 108
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 108
Relationships between daily physical activity combinations and psychophysical health status of Italian breast cancer survivors 108
The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects 107
Oral etoposide and platinum derivates in the treatment of metastatic Merkel cell carcinoma: report of three cases 107
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 107
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 104
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 103
Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer 103
Possible role of thymidylate synthase level in hunan colorectal carcinoma: a new prognostic factor? 102
Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function 102
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies 102
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. 101
Flexibility and Strength Effects of Adapted Nordic Walking and Myofascial Exercises Practice in Breast Cancer Survivors and Analysis of Differences 99
Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study 99
Neoadjuvant Chemotherapy for Surgically Staged IIIA N2 Non-Small Cell Lung Cancer (NSCLC) in the Elderly 98
Pretreatment neutrophil-lymphocyte ratio (NLR) predicted overall survival (OS) for metastatic melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC) patients who received monotherapy with immune checkpoint inhibitor as ipilimumab, nivolumab and pembrolizumab 97
Prognostic value of a novel interferon-inducible 90K tumor antigen 96
Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST). 96
Impact of Body Mass Index (BMI) on outcome of metastatic breast cancer (MBC) patients (pts) treated with Eribulin in a real-world population: a multicenter retrospective study 96
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 95
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting 94
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 93
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 92
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 92
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 91
FPSE-HPLC-DAD metod for the quantification of anticancer drugs in human whole blood, plasma and urine 90
Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression 89
Current challenges in HER2-positive breast cancer 88
Infusione cronomodulata di farmaci in oncologia 87
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. 87
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer 86
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 86
Totale 13.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 0 0 0 0 0 0 0 63
2021/2022557 19 15 5 118 34 32 15 46 33 15 62 163
2022/20231.842 143 236 160 191 190 329 98 155 210 16 70 44
2023/20241.029 86 31 66 44 64 329 173 30 41 33 25 107
2024/20252.361 137 390 324 109 61 118 116 125 223 176 257 325
2025/20265.923 400 199 498 553 543 330 978 293 1.204 482 319 124
Totale 14.806